Vanessa Pataia

At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.

Articles by Vanessa Pataia

News

Final Approval Sought for Phase 2 Trial of Repurposed NP-120 for IPF

Algernon Pharmaceuticals announced that it submitted a request for the final approval needed to open a…

News

Software May Predict IPF Progression Based on Chest Scans

A software program called CALIPER may be useful in predicting the progression of idiopathic pulmonary…

News

Peroxiredoxin-4 May Be Useful Biomarker for Early Detection of Acute Exacerbations in IPF, Study Suggests

The protein peroxiredoxin-4 may be a useful blood marker in the early detection of acute exacerbation of idiopathic pulmonary…

News

Scholar Rock Receives $25M for Continued Research in Potential Therapies for Fibrotic Diseases

Biopharmaceutical company Scholar Rock received $25 million from Gilead Sciences to continue the development of potential therapies to…

Subscribe to our newsletter

Get regular updates to your inbox.